On May 25, 2022, at the annual meeting of shareholders of Safeguard Scientifics, Inc. Ross D. DeMont and Beth S. Michelson were elected as directors of the Company, to serve until the Company's 2023 annual meeting of shareholders and until a successor is elected and qualified. Mr. DeMont will serve on the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee of the Company's Board of Directors. Mr. DeMont will also serve as the Chairman of the Compensation Committee.

Ms. Michelson will serve on the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee of the Company's Board of Directors. Mr. DeMont is currently Chief Investment Officer at the Rainin Group, Inc., which manages the assets of both a family office and the investments of the Kenneth Rainin Foundation. Previously, Mr. DeMont was a Managing Member and Portfolio Manager of Midwood Capital Management, a private investment partnership making concentrated investments in public companies.

Before this role, Mr. DeMont was an Associate at Igoe Capital Partners, a hybrid public/private equity investment firm with a primary focus on the small- and micro-cap sectors. Mr. DeMont also worked at Presidio strategies in Mergers and Acquisitions and JP Morgan with a focus on Corporate Finance and Mergers and Acquisitions. He previously served on multiple Boards of Directors, including Desalitech and Sierra Monitor Corp.

Ms. Michelson is a private equity investor with more than two decades of building businesses globally. In addition to having served on audit and compensation committees, Ms. Michelson is also a Chartered Financial Analyst and has structured and deployed over $500 million of investment capital. Ms. Michelson is currently a Senior Managing Director at Cartesian Capital, a growth oriented private equity firm and is on the management team of two SPACS, Cartesian Growth Corporation I and II, where she serves as CFO and Director.